# Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tislelizumab-combined-with-chemotherapy-as-neoadjuvant-therapy-for-surgically/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xiaolong Yan,Hongtao Duan,Yunfeng Ni,Yongan Zhou,Xiaoping Wang,Haini Qi,L. Gong,Honggang Liu,Feng Tian,Qiang Lü,Jianyong Sun,Ende Yang,Daixing Zhong,Tao Wang,Lijun Huang,Jian Wang,chaoyang Wang,Yuanyong Wang,Zhiyi Wan,Jie Lei,Jinbo Zhao,Tao Jiang |
| Citations | 237 |
| DOI | 10.1016/j.ijsu.2022.106680 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4280643802 |
| PMID | 35595021 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Qiang Lü](https://scholariq.org/researchers/qiang-lu/)
- [Jian Wang](https://scholariq.org/researchers/jian-wang-3/)

## Paper journal

- [International Journal of Surgery](https://scholariq.org/journals/international-journal-of-surgery/)

## Paper primary topic

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

## Paper topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.